Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Not recommended.
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
Testing is not New York state approved. Specimens from New York clients will be sent out to a New York state-approved laboratory.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
CSF.
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Transfer 0.5 mL CSF to an ARUP Standard Transport Tube. (Min: 0.3 mL) New York State Clients: 1 mL (Min: 0.1 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Refrigerated. Also acceptable: Frozen. New York State Clients: Refrigerated
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Contaminated, heat-inactivated, hemolyzed, or xanthochromic specimens.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
Ambient: 8 hours; Refrigerated: 2 weeks; Frozen: 1 year New York State Clients: Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 month
Methodology
Process(es) used to perform the test.
Semi-Quantitative Chemiluminescent Immunoassay
Performed
Days of the week the test is performed.
Sun-Sat
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
Within 24 hours
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Effective August 20, 2012
8.9 AU/mL or less
Negative - No significant level of detectable IgG mumps virus antibody.
9.0-10.9 AU/mL
Equivocal - Repeat testing in 10-14 days may be helpful.
11.0 AU/mL or greater
Positive - IgG antibody to mumps virus detected, which may indicate a current or past mumps virus infection.
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
The detection of antibodies to mumps virus in CSF may indicate central nervous system infection. However, consideration must be given to possible contamination by blood or transfer of serum antibodies across the blood-brain barrier.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Compliance Category
Modified FDA
Note
Additional information related to the test.
Hotline History
N/A
CPT Codes
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Connect Sign In
